Phase 2 Study of Belantamab Mafodotin As Pre- and Post-Stem Cell Transplant Consolidation and Maintenance (BLAST study) for Multiple Myeloma Patients in First Remission

被引：0
|
作者：
Cohen, Adam D. [1 ]
Garfall, Alfred L. [2 ]
Susanibar-Adaniya, Sandra Patricia [2 ]
Vogl, Dan T. [2 ]
Waxman, Adam [2 ]
De Mesa, Oksana [2 ]
Kane, Elizabeth [3 ]
Nichols, Charles [4 ]
Razzo, Beatrice [2 ]
Stadtmauer, Edward A. [2 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[3] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-165526
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
653
引用
收藏
页码：12628 / 12629
页数：2
相关论文
共 50 条
  • [41] A phase II study of sequential velcade/thalidomide/dexamethasone as maintenance therapy post single autologous peripheral stem cell in patients with multiple myeloma
    Sahebi, F.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S148 - S148
  • [42] An interim analysis of a phase I/II single arm study of belantamab mafodotin, carfilzomib and dexamethasone in patients with relapsed multiple myeloma: AMaRC 19-02 BelaCarD study
    Lasica, Masa
    Spencer, Andrew
    Campbell, Philip
    Wallington-Gates, Craig
    Doo, Nicole Wong
    Janowski, Wojciech
    McCaughan, Georgia
    Puliyayil, Anish
    Yuen, Flora
    Le, Khoa
    Reynolds, John
    Quach, Hang
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S29 - S30
  • [43] Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004–2014
    A D'Souza
    M-J Zhang
    J Huang
    M Fei
    M Pasquini
    M Hamadani
    P Hari
    Leukemia, 2017, 31 : 1998 - 2000
  • [44] The efficacy of salvage autologous stem cell transplant among patients with multiple myeloma who received maintenance therapy post initial transplant
    Manjappa, Shivaprasad
    Fiala, Mark A.
    King, Justin
    Kohnen, Daniel A.
    Vij, Ravi
    BONE MARROW TRANSPLANTATION, 2018, 53 (11) : 1483 - 1486
  • [45] Post Autologous Stem Cell Transplant Maintenance in Patients with Newly Diagnosed Multiple Myeloma: A Network Meta-Analysis
    Naqvi, Syed Arsalan Ahmed
    Fatima, Sarosh
    Asghar, Noureen
    Ijaz, Hafsah
    Ayaz, Ahsan
    He, Huan
    Husnain, Muhammad
    Chakraborty, Rajshekar
    Riaz, Irbaz
    Aljama, Mohammed A.
    BLOOD, 2022, 140 : 10111 - 10113
  • [46] Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study
    Farooq, Asim, V
    Degli Esposti, Simona
    Popat, Rakesh
    Thulasi, Praneetha
    Lonial, Sagar
    Nooka, Ajay K.
    Jakubowiak, Andrzej
    Sborov, Douglas
    Zaugg, Brian E.
    Badros, Ashraf Z.
    Jeng, Bennie H.
    Callander, Natalie S.
    Opalinska, Joanna
    Baron, January
    Piontek, Trisha
    Byrne, Julie
    Gupta, Ira
    Colby, Kathryn
    OPHTHALMOLOGY AND THERAPY, 2020, 9 (04) : 889 - 911
  • [47] Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study
    Asim V. Farooq
    Simona Degli Esposti
    Rakesh Popat
    Praneetha Thulasi
    Sagar Lonial
    Ajay K. Nooka
    Andrzej Jakubowiak
    Douglas Sborov
    Brian E. Zaugg
    Ashraf Z. Badros
    Bennie H. Jeng
    Natalie S. Callander
    Joanna Opalinska
    January Baron
    Trisha Piontek
    Julie Byrne
    Ira Gupta
    Kathryn Colby
    Ophthalmology and Therapy, 2020, 9 : 913 - 915
  • [48] A PHASE I STUDY OF BENDAMUSTINE AND MELPHALAN CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANT IN MULTIPLE MYELOMA
    Mark, T. M.
    Niesvizky, R.
    Gergis, U.
    Pearse, R. N.
    Mayer, S.
    Feldman, E. J.
    Shore, T. B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S199 - S199
  • [49] A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplant in Multiple Myeloma
    Mark, Tomer M.
    Reid, Whitney
    Niesvizky, Ruben
    Gergis, Usama
    Pearse, Roger N.
    Mayer, Sebastian
    Coleman, Morton
    Feldman, Eric J.
    Shore, Tsiporah B.
    BLOOD, 2011, 118 (21) : 895 - 895
  • [50] Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma
    Coffey, David G.
    Osman, Keren
    Aleman, Adolfo
    Bekri, Selma
    Kats, Simone
    Dhadwal, Amishi
    Catamero, Donna
    Kim-Schulze, Seunghee
    Gnjatic, Sacha
    Chari, Ajai
    Parekh, Samir
    Jagannath, Sundar
    Cho, Hearn Jay
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
12345